Tag: Keytruda
-
Merck Application for Lung Cancer Combo Therapy Accepted by FDA
Merck & Co have applied to the FDA for approval to combine their immunotherapy drug, Keytruda, with chemotherapy as an initial treatment for advanced lung cancer. The FDA agreed to expedite the case, and give the application a much faster review. Merck released a statement saying the U.S. Food and Drug Administration (FDA) would reach…